Abstract:In cells of the myeloid lineage, NLRP3 stimulation leads to disassembly of the trans‐Golgi network (TGN). The resulting dispersed TGN serves as a scaffold for NLRP3 aggregation, leading to cytokine production and pyroptosis. In contrast, it is proposed that the magnitude of interactions between the polybasic motif of NLRP3 and the TGN in adaptive immunity is low, which triggers cytokine production, but does not result in pyroptotic cell death. Eukaryotic cells are equipped with cytoplasmic sensors that recognize diverse pathogen‐ or danger‐associated molecular patterns. In cells of the myeloid lineage, activation of these sensors leads to the assembly of a multimeric protein complex, called the inflammasome, that culminates in the production of inflammatory cytokines and pyroptosis. Recently, investigation of the inflammasomes in lymphocytes led to the discovery of functional pathways that were initially believed to be confined to the innate arm of the immune system. Thus, the adapter protein apoptosis‐associated speck‐like protein containing a CARD (ASC) was documented to play a critical role in antigen uptake by dendritic cells, and regulation of T‐ and B‐cell motility at several stages, and absent in melanoma 2 (AIM2) was found to act as a modulator of regulatory T‐cell differentiation. Remarkably, NLRP3 was demonstrated to act as a transcription factor that controls Th2 cell polarization, and as a negative regulator of regulatory T‐cell differentiation by limiting Foxp3 expression. In B lymphocytes, NLRP3 plays a role in the transcriptional network that regulates B‐cell development and homing, and its activation is essential for germinal center formation and maturation of high‐affinity antibody responses. Such recently discovered inflammasome‐mediated functions in T and B lymphocytes offer multiple cross‐talk opportunities for the innate and adaptive arms of the immune system. A better understanding of the dialog between inflammasomes and intracellular components could be beneficial for therapeutic purposes in restoring immune homeostasis and mitigating inflammation in a wide range of disorders.

Bif‐1 inhibits activation of inflammasome through autophagy regulatory mechanism

The Inhibitor Effect of RKIP on Inflammasome Activation and Inflammasome-Dependent Diseases

IF1 inactivation attenuates experimental colitis through downregulation of neutrophil infiltration in colon mucosa

Selective autophagy of the adaptor TRIF regulates innate inflammatory signaling

Lipopolysaccharide promotes NLRP3 inflammasome activation by inhibiting TFEB-mediated autophagy in NRK-52E cells

Brefeldin A-sensitive ER-Golgi vesicle trafficking contributes to NLRP3-dependent caspase-1 activation

HUWE1 mediates inflammasome activation and promotes host defense against bacterial infection

Inhibition of NLRP1 inflammasome improves autophagy dysfunction and Aβ disposition in APP/PS1 mice

Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy

Basal autophagy prevents autoactivation or enhancement of inflammatory signals by targeting monomeric MyD88

The CARD8 T60 variant associates with NLRP1 and negatively regulates its activation

MafB regulates NLRP3 inflammasome activation by sustaining p62 expression in macrophages

Swaying the advantage: multifaceted functions of inflammasomes in adaptive immunity

AMBRA1 Promotes Intestinal Inflammation by Antagonizing PP4R1/PP4c Mediated IKK Dephosphorylation in an Autophagy-Independent Manner

The E3 Ubiquitin Ligase TRIM65 Negatively Regulates Inflammasome Activation Through Promoting Ubiquitination of NLRP3

IKKβ mediates homeostatic function in inflammation via competitively phosphorylating AMPK and IκBα

Inflammasome Activity is Controlled by ZBTB16-dependent SUMOylation of ASC

Inflammasome functional activities in B lymphocytes

Role of Autophagy in LPS‑induced Inflammation in INS‑1 Cells.

IRGM/Irgm1 increases autophagy to inhibit activation of NLRP3 inflammasome in inflammatory injury induced acute liver failure

ATG16L2 inhibits NLRP3 inflammasome activation through promoting ATG5-12-16L1 complex assembly and autophagy